Advances in the Treatment of Multiple myeloma / 昆明医科大学学报
Journal of Kunming Medical University
;
(12): 1-4, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-514132
ABSTRACT
Multiple myeloma is a monoclonal plasma cell malignant proliferative disease,accounting for about 10% of malignaut tumors of blood system.In recent years,due to the application of hematopoietic stem cell transplantation and the application of MDT by combining new drug such as thalidomide,lenalidomide and bortezomib,the average survival of MM patients was significantly longer than before.The treatment strategy should be individualized before treatment according to the patient's age,physical condition and complications.In this paper,the treatment strategy of multiple myeloma patients were reviewed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Kunming Medical University
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS